GRIFOLS | GRF - Current Assets


GRIFOLS reported EUR5.31B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Alcon AG USD 6.62B 171M Mar/2026
Almirall EUR 747.1M 33.12M Jun/2026
Amadeus IT EUR 2.64B 324.6M Jun/2026
Amarin USD 602.76M 23.26M Jun/2026
argenx SE USD 8.07B 1.17B Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
Bayer EUR 35.3B 2.39B Mar/2026
Cie Automotive EUR 1.8B 6.22M Dec/2025
Demant DKK 10.08B 128M Dec/2025
Ence Energia y Celulosa EUR 396.7M 9.37M Mar/2026
Essilor EUR 11.24B 770M Jun/2026
Ferrovial EUR 6.81B 500M Jun/2026
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.56B 202M Jun/2026
GRIFOLS EUR 5.31B 51M Jun/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Inditex EUR 16.09B 402M Mar/2026
Lakefront Biotherapeutics EUR 3.06B 18.72M Mar/2026
Merck EUR 14.16B 932M Mar/2026
Novartis USD 27.35B 744M Jun/2026
Philips EUR 9.33B 454M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Smith & Nephew USD 4.63B 169M Dec/2025
UCB EUR 6.05B 733M Dec/2025
Viscofan EUR 862.44M 7.79M Jun/2026